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COVID-19: RECOVERY CERTIFICATES
Patients who have recovered from covid-19: issuing certificates and
offering voluntary registration
Raj Bhopal emeritus professor of public health
In my rapid response of 21 March,1 updated 9 April
2020,2 about covid-19 creating extraordinary times
demanding imaginative responses,3 I wrote that
peoplewhohad recovered fromproven infection and
werenot shedding viruswere apotentially invaluable
asset. Having recovered, I inferred, they must have
at least partial, temporary immunity. I recommended
that we give them a certificate indicating that they
would be largely, if not wholly, immune to a second
infection this year.
I anticipated reliable antibody testingwouldbecome
available, providing further reassurance on immune
status, which is becoming true, although it is a
controversialmatter.4Evena testwith 99%sensitivity
and specificity only has 83.8% predictive power of a
positive test when the prevalence of infection is 5%.5
(A supplementary file provides 12 simple tables of
sensitivity, specificity, and predictive powers of
positive and negative tests at population prevalence
of the disease ranging from 1% to 20%.5)
I proposed that, with care, recovered patients could
serve on the front line, not just in healthcare and
nursing homes but also in retailers and factories.
With their permission they could be offered
registration for employment and volunteering
purposes. Theymight earnapremium income turning
their disease into an asset for themselves and society.
I identified clinical, public health, legal, ethical, and
social issues requiring research and scholarship as
well as public debate.1 2 The Royal College of
Physicians of Edinburgh hosted a video on this
proposal (https://learn-
ing.rcpe.ac.uk/course/view.php?id=707).
Since then, there has beenmuch scholarly andmedia
baseddebate especially about “immunity passports,”
much of the controversy around antibody
testing.4 6 -10 The phrase immunity passport implies
a guarantee that cannot be achieved. The World
Health Organization cautioned against this on 24
April.11 I have, however, not changed my mind and
think the emphasis on antibody testing is misplaced
and is unnecessary, especially as much immunity to
respiratory viruses is largely not humoral.12 It is a
matter of probabilities, as there can never be
certainties.
Public involvement has been slow despite media
publicity. Chile, tomy knowledge, is the first country
to formally adopt this proposal. Scientific literature
records differing opinions but discusses obstacles
and benefits.6 -9 It is time to go beyond opinion, but
research is just getting under way. The public,
scholars, and policy makers together need to debate
this idea as a component of exit strategies. I think the
public, and especially thosewhohave been ill,might
find the ideamore attractive thanmy fellow scholars
and researchers. Is it time for a citizens’ jury?
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